Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2024 Nov 11;24:1382. doi: 10.1186/s12885-024-13152-2

Correction: Is interval chemotherapy safe and does it improve the outcome of patients with colorectal liver metastases undergoing multimodal two-stage hepatectomy? – A systematic literature review

Nathanael Raschzok 1,3,, Simon Moosburner 1,3, Moritz Blank 1, Felix Krenzien 1,3, Georg Lurje 1, Wenzel Schöning 1, Igor M Sauer 1, Johann Pratschke 1, Dominik P Modest 2, Annika Kurreck 2
PMCID: PMC11552103  PMID: 39528976

Correction: BMC Cancer 24, 1260 (2024)

10.1186/s12885-024-13008-9.

Following publication of the original article [1], it was reported that the ORCID of the first author, Nathanael Raschzok, was missing. The ORCID is: https://orcid.org/0000-0001-5074-7063.

The original article [1] has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s12885-024-13008-9.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Raschzok N, Moosburner S, Blank M, et al. Is interval chemotherapy safe and does it improve the outcome of patients with colorectal liver metastases undergoing multimodal two-stage hepatectomy? – a systematic literature review. BMC Cancer. 2024;24:1260. 10.1186/s12885-024-13008-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES